Hanan Musawi, MD
Psychiatry · Raleigh, NCNPI 1487032835
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 18 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 17.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $262 and has fallen 66.9% since, to $87 in 2025.
Across 18 payments — averaging $26.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$85
- Otsuka America Pharmaceutical, Inc.$80
- Livanova USA, Inc.$79
- E.r. Squibb & Sons, L.L.C.$56
- Brainsway USA Inc$55
- Teva Pharmaceuticals USA, Inc.$31
- plus $97 from 5 others
What the payments were for
- Food & beverage$483100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$483 in reported general payments places this provider in the 65th percentile of 1,108 psychiatry providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trazodone Hcl | 13 | $179 |
| Sertraline Hcl | 13 | $158 |
| Gabapentin | 13 | $129 |
| Clonazepam | 16 | $77 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Raleigh
- Robert MilletRaleigh$476K
- Richard WeislerRaleigh$108K
- Ashwin PatkarRaleigh$103K
- Mona GuptaRaleigh$88K
- Kellie TolinRaleigh$31K
- Celso LobaoRaleigh$28K
- Elizabeth CoxRaleigh$24K
- Myleme HarrisonRaleigh$13K
- Craig ChepkeHuntersville$4.1M
- Mark ReynoldsDurham$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.